Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Movicol augmentation of bowel preparation for outpatient colonoscopy
ACTRN12616000712404Phase 4Terminated
- Sponsor
- Alfred Health
- Start
- Apr 2016
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol in gastrointestinal conditions (2 arms), sponsored by Alfred Health. Primary endpoint: Quality of bowel preparation. Started Apr 2016; status: terminated.
02
Drugs
polyethylene glycol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ACTRN12616000712404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000712404.